Medical devices, healthcare technology and the business of care
510(k) clearance · K260421

LuxDesign

LuxCreo, Inc. · Decision date Oct 23, 2026

MEDTECHLEDGER EXPLANATIONK260421

What did the FDA decide?

LuxDesign, submitted by LuxCreo, Inc. of Chicago, Illinois, is listed under the device classification Orthodontic Software (21 CFR 872.5470), product code PNN with subsequent product code LLZ, in the Dental specialty. FDA recorded receipt on 02/09/2026 and issued a decision dated 2026-10-23 of Substantially Equivalent (SESE) under 510(k) number K260421. This is a clearance, not a PMA approval.

The filing is recorded as a Traditional 510(k) with a Statement, not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. The public record does not describe the specific software functions, components, predicates, or any changed item, and no summary is listed for this number; those details would require the underlying FDA documents.

Because the record is limited to administrative fields, no clinical performance, labeling scope, or patient-selection information can be attributed to this clearance, and none should be inferred from the classification name alone.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Oct 23, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260421
Regulatory pathway
510(k) premarket notification
Applicant
LuxCreo, Inc.
Product code
PNN
Decision code
SESE
Decision date
Oct 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Orthodontic Software.

Applicant
LuxCreo, Inc.
Product code
PNN
FDA device class
2

FDA decision timeline

  1. K260421 received

    Application receipt date recorded by FDA.

  2. K260421 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code PNN

Product / regulatory recordCompanyPathwayDecision dateSource
InnoDtech, Inc.510(k) clearanceOct 7, 2026FDA
Align Technology, Inc.510(k) clearanceSep 25, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

LuxCreo, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Chicago, IL

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records